I.V. Selonabant in Healthy Adult Subjects

Clinical trial NCT07211607 · COMPLETED

Trial details

NCT number: NCT07211607
Sponsor: Anebulo Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-09-22
Primary completion: 2026-05-06
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.